Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

Episode 52 April 23, 2025 00:52:05
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

Apr 23 2025 | 00:52:05

/

Show Notes

How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far Between podcast!

Host Chris O'Brien welcomes Joshua Kresh, Emily Michiko Morris, and Mark Schultz from IPPI: The Intellectual Property Policy Institute. Tune in for a fascinating discussion on the dos and don'ts of IP protection.

Listen to the latest episode today!

Other Episodes

Episode 55

July 09, 2025 00:38:46
Episode Cover

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks...

Listen

Episode 30

May 23, 2023 00:35:12
Episode Cover

Episode 30, Part Two: Dr. Francisco Harrison, CEO and owner, Harrison CST Holding GmbH

"We have to rethink the sense of clinical research from the point of view that if we have the possibility to have markers that...

Listen

Episode 43

September 12, 2024 00:39:18
Episode Cover

Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics

"I hope we're moving into the age of the generalist, where knowing how to learn and learning how to learn are more important than...

Listen